Doubts over the long-term safety of the HIV nucleoside reverse transcriptase inhibitor abacavir and the less commonly used antiretroviral drug didanosine are raised in a research Article. Both drugs were found to be associated with an increased risk of myocardial infarction. Jens Lundgren (University of Copenhagen, Denmark) discusses the study in this week's podcast.